ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes
Thursday Oct 22, 2020
Thursday Oct 22, 2020
North Dakota was one of the 5 jurisdictions selected to do a pilot for COVID-19 vaccine planning. We chat with contacts from North Dakota who were at the table for those planning discussions.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 21, 2020
Wednesday Oct 21, 2020
: Elizabeth Pogge, Professor at Midwestern University and Gina Luchen, ASHP’s Director of Academic Programs discuss the importance of creating precepting habits that stick. Dr. Pogge addresses common preceptor challenges and pearls in preparation for ASHP’s National Pharmacy Preceptors Conference.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 21, 2020
Wednesday Oct 21, 2020
What do innovation, 3-D printers and an old federal reserve bank vault in Philadelphia have to do with Pharmacy? Join Vicki Basalyga as she sits down with the co-founder of the Health Design Lab and Director of Innovation Design at Thomas Jefferson Rob Pugliese, as he shares how his experience as a pharmacist prepared him to step outside his comfort zone and create a space built with the purpose of merging together design-studio ethos with science-oriented discipline to foster innovation in healthcare.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Oct 16, 2020
Friday Oct 16, 2020
This podcast will discuss the recent data published on the potential role of SGLT2 inhibitors for patients with heart failure with and without diabetes.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Oct 15, 2020
Thursday Oct 15, 2020
The 340B program is under attack from CMS and drug manufacturers. Tom Kraus and Jillanne Schulte-Wall help you understand recent threats to the program and how ASHP is fighting back.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Oct 15, 2020
Thursday Oct 15, 2020
HHS just released a series of new policies including a new health plan proposal, drug importation rules, and changes to Medicare billing. Tom Kraus and Jillanne Schulte-Wall provide a roundup of these policy changes and help you understand how they are likely to be implemented and the challenges they will face.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 14, 2020
Wednesday Oct 14, 2020
ASHP is drawing on the PAI 2030 recommendations to promote “focused initiatives” intended to propel changes in pharmacy practice that will have a major impact on the responsible use of medicines. The focused initiatives are time-bound, aligned with the PAI 2030 recommendations, and intended to help speed adoption of best practices in pursuit of large-scale change.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Oct 12, 2020
Monday Oct 12, 2020
Rita Shane and Charles Daniels discuss the clinical aspects of health care and its fundamental role in effective leadership.
Date recorded: January 23, 2018
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 07, 2020
Wednesday Oct 07, 2020
Join the Section of Pharmacy Practice Leaders Multi-Hospital Pharmacy Executives Committee as they discuss COVID-19 vaccine administration, allocation, and distribution. The Committee’s fourteen multi-hospital pharmacy executives joined by Health-System Pharmacy Administration and Leadership Residents discuss:
- Concerns about resistance to accepting the vaccine
- Organizational planning to manage patients’ that may not have received the COVID-19 vaccine
- Considerations around mandating COVID-19 vaccination for all employees
- How pharmacists and technicians fit into organizations’ planning for tiered selection
- Logistics of the supply chain (including management of vaccine once on-site and the associated capital equipment and disposables)
- Role of the pharmacy as it relates to the management of COVID-19 vaccines and vaccination
- Engagement with state departments of health
- Interoperability with immunization information systems/registries and EHRs considering the management of the various COVID-19 vaccine formulations
Special acknowledgement to the podcast virtual roundtable participants: (Chair) Richard Myers, Pharm.D., M.B.A., BCPS; (Vice Chair) Christy Norman, Pharm.D., M.S., BCPS; Brian Cotter, M.S., R.Ph.; Jordan Dow, Pharm.D., M.S., FACHE; Connor Hanson, Pharm.D.; Eleni Kalivas, Pharm.D.; Kevin Krueger, Pharm.D., M.B.A.; Dave Lacknauth, Pharm.D, M.S., M.B.A.; Indu Lew, Pharm.D.; Tim Lynch, Pharm.D., M.S., FABC, FASHP; Karen McConnell, Pharm.D., FCCP, FASHP, BCPS; Shawn Osborne, Pharm.D., M.B.A., CMRP; Binita Patel, Pharm.D., M.S.; Kuldip Patel, Pharm.D.; Matthew Pond, Pharm.D., M.B.A.; Suzanne Shea, RPh, M.B.A.; Rebecca Taylor, Pharm.D., MBA, BCPS, FASHP; (ASHP Staff - David Chen, R.Ph., M.B.A. and Anna Legreid Dopp, Pharm.D.)
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 07, 2020
Wednesday Oct 07, 2020
Nick Gentile, ASHP’s Director of PAC and Grassroots Engagement, and Tom Kraus, ASHP’s Vice President of Government Relations, analyze the arguments before the Supreme Court in Rutledge vs PCMA, and share a perspective on how the court might rule.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.